India's Lal PathLabs set for best day ever after quarterly results

Dr. Lal PathLabs

04/05/2026 06:32

** Shares of India's Lal PathLabs DLPA.NS jump 18.58% to 1,621.20 rupees, on course for best day ever, if gains hold

** Diagnostics firm's Q4 revenue rose 16.6% y/y, aided by growth in sample volumes, higher patient additions

** Phillip Capital ("buy", PT: 1,800 rupees) raises FY27 and FY28 earnings estimates by 2% and 7%, respectively, on better-than-expected revenue guidance

** ICICI Securities cuts PT by 40 rupees to 1,460 rupees; estimates 13% revenue and 14.2% EBITDA CAGR over FY26–FY28

** Cuts FY27 and FY28 PAT estimates by ~1% and ~3%, respectively, citing near-term margin pressure from expansion investments

** Trading vols at 2.3 mln shares, nearly 7x the 30-day average

** YTD, stock up ~1.5%

($1 = 94.8687 Indian rupees)

(Reporting by Bipasha Dey in Bengaluru)

((Bipasha.Dey@thomsonreuters.com;))